Stock Track | Erasca Plummets 5.39% Intraday After Bank of America Maintains Sell Rating with $2 Target

Stock Track03-14

Erasca, Inc. (ERAS) shares plummeted 5.39% during intraday trading on Friday, reflecting negative market sentiment following analyst actions.

The decline comes after Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on the biopharmaceutical company and set a price target of just $2.00. This bearish outlook contrasts with some other analysts who have been more positive, creating uncertainty among investors.

Adding to the cautious environment, Erasca is scheduled to report its quarterly earnings later in the week, with analysts expecting a loss per share. The combination of a prominent sell-side firm maintaining a strongly negative stance ahead of earnings appears to have driven the stock's downward movement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145947805?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-14 00:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145947805","market":"sg","top_or_hot":-1,"title":"Stock Track | Erasca Plummets 5.39% Intraday After Bank of America Maintains Sell Rating with $2 Target","media":"Stock Track","content":"<p>Erasca, Inc. (ERAS) shares plummeted 5.39% during intraday trading on Friday, reflecting negative market sentiment following analyst actions.</p><p>The decline comes after Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on the biopharmaceutical company and set a price target of just $2.00. This bearish outlook contrasts with some other analysts who have been more positive, creating uncertainty among investors.</p><p>Adding to the cautious environment, Erasca is scheduled to report its quarterly earnings later in the week, with analysts expecting a loss per share. The combination of a prominent sell-side firm maintaining a strongly negative stance ahead of earnings appears to have driven the stock's downward movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Erasca Plummets 5.39% Intraday After Bank of America Maintains Sell Rating with $2 Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Erasca Plummets 5.39% Intraday After Bank of America Maintains Sell Rating with $2 Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-14 00:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Erasca, Inc. (ERAS) shares plummeted 5.39% during intraday trading on Friday, reflecting negative market sentiment following analyst actions.</p><p>The decline comes after Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on the biopharmaceutical company and set a price target of just $2.00. This bearish outlook contrasts with some other analysts who have been more positive, creating uncertainty among investors.</p><p>Adding to the cautious environment, Erasca is scheduled to report its quarterly earnings later in the week, with analysts expecting a loss per share. The combination of a prominent sell-side firm maintaining a strongly negative stance ahead of earnings appears to have driven the stock's downward movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ERAS","symbol_name":"Erasca, INC.","start_time":0,"source_url":"","article_id":"1145947805","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145947805","pubTimestamp":1773419195,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Erasca, Inc. (ERAS) shares plummeted 5.39% during intraday trading on Friday, reflecting negative market sentiment following analyst actions.The decline comes after Bank of America Securities analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ERAS":"Erasca, INC."},"translate_title":"个股追踪|美银维持卖出评级目标2美元Erasca盘中暴跌5.39%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ERAS":1},"content_text":"Erasca, Inc. (ERAS) shares plummeted 5.39% during intraday trading on Friday, reflecting negative market sentiment following analyst actions.The decline comes after Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on the biopharmaceutical company and set a price target of just $2.00. This bearish outlook contrasts with some other analysts who have been more positive, creating uncertainty among investors.Adding to the cautious environment, Erasca is scheduled to report its quarterly earnings later in the week, with analysts expecting a loss per share. The combination of a prominent sell-side firm maintaining a strongly negative stance ahead of earnings appears to have driven the stock's downward movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145947805","isCrawlerRequest":true}